Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report)’s stock price traded down 1% during mid-day trading on Wednesday. The stock traded as low as $16.37 and last traded at $16.51. 16,218 shares traded hands during trading, a decline of 20% from the average session volume of 20,170 shares. The stock had previously closed at $16.67.
Fortress Biotech Stock Up 4.5%
The stock’s 50 day moving average is $18.33 and its 200 day moving average is $17.27.
Fortress Biotech Company Profile
Fortress Biotech, Inc is a biopharmaceutical company focused on developing and commercializing medicines for serious diseases with significant unmet medical needs. The company uses a subsidiary-based business model in which specialized biotechnology companies advance therapies in areas including oncology, dermatology, rare diseases, infectious diseases and neurology.
Fortress and its subsidiaries develop products across multiple stages, from early research and clinical development to regulatory approval and commercialization.
See Also
- Five stocks we like better than Fortress Biotech
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
